Focusing first onAngptl7,wefindthatprior
RNA sequencing (RNA-seq) data ( 28 )showed
thatAngptl7was not even expressed in the
primed HG cells of telogen or early anagen
HFs (Fig. 4C and fig. S8D). To delineate the
detailed temporal changes ofAngptl7within
bulgeSCs,weperformedstage-specific single-
cell RNA-seq. Three distinct temporal patterns
emerged from t-distributed stochastic neigh-
bor embedding (t-SNE) and unsupervised hier-
archical clustering (Fig. 4D and fig. S8E). Using
machine learning–based cell-cycle allocation
analysis ( 29 ), it was concluded that prolifer-
ative cells resided in AnaII SCs, in agreement
with our 5-ethynyl-2′-deoxyuridine (EdU) label-
ing studies. Additionally, in contrast to SC
markerSox9, which was maintained in bulge
SCs at all stages,Angptl7transcription in bulge
SCs diminished shortly after anagen onset,
even sooner than that of established quiescence
regulatorNfatc1( 28 ). Moreover, theAngptl7
expression dip was transient, occurring only
between AnaII and AnaIII (Fig. 4E).
Angptl7dynamics were recapitulated at the
chromatin level. As judged by chromatin immu-
noprecipitation sequencing (ChIP-seq) analyses
of fluorescence-activated cell sorting (FACS)–
purified HF cells ( 30 ), theAngptl7chroma-tin state was active in telogen (H3K27ac+),
poised in AnaIII (H3K27acnegH3K4me1+),
and silent in AnaVI differentiated cells
(H3K27acnegH3K4me1neg) (fig. S9A). More-
over, when either of the twoAngptl7locus–
accessible chromatin elements ( 30 )wereused
as enhancers to drive enhanced green fluores-
cent protein (eGFP) expression in vivo, report-
ers faithfully recapitulatedAngptl7’s temporal
dynamics in bulge expression during the hair
cycle (Fig. 4F and fig. S9B). These results
intimated that changes in SC-derivedAngptl7
transcription are involved in reshaping the
regenerative microenvironment of the niche.Gur-Cohenet al.,Science 366 , 1218–1225 (2019) 6 December 2019 3of8
Prox1-CreER+ ; iDTRflTAMTAMTAMTAMDT Analysis2 nd
Telogen
P60 (Day 0)Full Ana
P15Day 1-10x1x1 Crx1 Cr-CrAMCrreEERRR++;iiDTRRRflTTTATTTArreErER;iiDTRATTTAreEERR; iDTRiAMAMAMDTT AnalysisLYVE1 patternProx1-CreER+;iDTRfl
Ctrl depleted (D10)CtrlTargeted lymphatic vessel depletionLYVE1 LYVE1Prox1-CreER+;iDTR-depleted (D10)HFs precociously enter anagen upon lymphatic vessel depletion50 μm
DAPI P-CAD SOX9 LYVE130 μmSCs exit quiescence upon depletionCtrl
Prox1-
depleted020406080100120%Hair folliclesTel-Ana I
Ana II-III
Ana IV-VP < 0.0001
P = 0.0347
P = 0.0013DyeCycle Violet
Day 1 post depletionS/M/G2G0/G1A0.00.51.01.52.02.5Lymphatic capillaries volume(per 1μm3 area)p = 0.0183Ctrl
Prox1-
depleted0500100015002000LYVE1 intensity(per μm3 ; a.u.)p = 0.0232Ctrl
Prox1-
depletedIgG Ctrl
VEGFR3-Fc01020304050EdU+ cells per follicleIgG Ctrl p < 0.0001
VEGFR3-FcKRT24 P-CAD EdU DAPI30 μm 30 μm 30 μmIgG/VR3-Fc Analysis2 nd
Telogen
(P60)IgG/VR3-FcIgG/VR3-FcIgG/VR3-FcP65IgG/VR3-FcLymphatic regression upon disruption of VEGFR3 signaling induces anagen entryIgG Ctrl
VEGFR3-Fc020406080100120% Hair folliclesTelogen-Ana IP < 0.0001
P < 0.0001
P = 0.9036Ana II-III
A Ana IV-V-Fc
IgIgG/VRIg Ig IgG/VR3-FIgGG/VR/3-F
c
IgG
/VR3-Fc
IgG
/VR3-Fc
IgG
/VR3-
IgG/IgG/VEGFR3-Fc
ID injectionB CDCtrlDepleted D1020406080100120Cell cycle profile in HFSCsG0/G1
S/M/G2p = 0.0045
p = 0.0051+DT
ID injectionCtrl
Depleted020406080100-10^30103104105Fig. 2. Disrupting lymphatic capillaries triggers hair regeneration.
(A) Timeline of experimental model and diphtheria toxin (DT)–induced
depletion of lymphatic vessels during the long quiescence of second telogen.
Quantifications: lymphatic intensity (n= 3); volume (n=5and4forCtrl
andProx1-depleted, respectively; two-tailed unpairedttest). ID, intradermal;
TAM, tamoxifen; P, postnatal day; Ctrl, control; D, day; a.u., arbitrary units.
(B) Precocious anagen induction after lymphatic depletion, as demonstrated
by HF growth and association with LYVE1+capillaries (n= 5, two-way ANOVA
with Sidak’s multiple comparisons test). P-CAD, P-cadherin. (C) Flow cytometry
of HFSC cell cycle after lymphatic depletion (n= 3, two-way ANOVA with Sidak’s
multiple comparisons test). (D) Experimental strategy using decoy VEGF3-Fc to
interrupt VEGFR3 signaling in dermal lymphatic vessels. EdU incorporation reveals
anagen entry after treatment (n= 4, multiple EdU measurements, two-tailed
unpairedttest). IgG, immunoglobulin G.RESEARCH | RESEARCH ARTICLE
on December 12, 2019^http://science.sciencemag.org/Downloaded from